TrialDiabetes, obesity & metabolism2020

Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study.

Munehide Matsuhisa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.